AHEL is planning to invest around Rs 500 crore during the current fiscal, through a mix of debt and internal accruals. It also said it was open to inorganic growth in Northeast India. Announcing its financial results for the quarter ended on March 31, 2014, the company said it added over 300 bed in 2013-2014.
The expansion plan includes the 200-bed hospital at Nellore and the 150-bed hospital in South Chennai. Both these facilities are expected to go on stream during the second quarter of the current fiscal, said Suneeta Reddy, joint managing director of AHEL.
She added the 125-bed hospital at Nasik, 200-bed facility at Mellavaram and a 250-bed facility at Vizag are expected to go on stream in the second half of current fiscal.
ALSO READ: Apollo Hospitals to invest Rs 2,000 cr on capacity upgrade
Apollo Hospitals has a total capacity of 8,617 beds as on Mar 31, 2014, including 39-owned hospitals.
ALSO READ: Apollo Hospitals launches Virtual Clinic in apartment complex
In April, it acquired a 51 per cent interest in a 125-bed hospital in Indore for Rs 26 crore, as part of expanding its operations. The acquired multi-speciality hospital is expected to undergo a capacity upgradation to 175 beds in the next 12-18 months.“Going forward, as we add more specialties, we can increase our stake,” said A Krishnan , chief financial officer of Apollo Hospitals, while addressing the Analysts.
“We are also looking at inorganic growth, especially in the Northeast,” he said.
ALSO READ: Apollo Hospitals to add cancer care facility to Navi Mumbai project
The 200-bed specialty hospital in Trichy was operationalised in the third quarter of the fiscal 2013-14, and is expected to achieve Ebitda breakeven within 12 months from its launch.
ALSO READ: Apollo Hospitals postpones plans to list in Singapore
Q4 net up 7.7 per centApollo Hospitals posted an increase of 7.7 per cent in net profit at Rs 81.34 crore for the quarter ended March 31, 2014, as against Rs 75.52 crore for the same period of the previous fiscal. Total income of the company reached Rs 998.18 crore for the quarter, compared with Rs 848.29 crore in the corresponding quarter previous year, marking an increase of 17.7 per cent.
Margins witnessed pressure considering investments made in developing the infrastructure and the time taken for the new facilities to generate profits, according to a company source. Higher number of standalone pharmacies also impacted its margins, the source added.